<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Healthcare Stock Tracker | Statmint</title>
  <meta name="description" content="Statmint's healthcare stock tracker: real biotech pipeline, trial status, stock trends and export tools.">
  <link rel="icon" href="statmint_logo.jpeg" type="image/jpeg" />
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet"/>
  <link href="https://unpkg.com/aos@2.3.4/dist/aos.css" rel="stylesheet"/>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&family=Merriweather:wght@700&display=swap" rel="stylesheet"/>
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  <style>
    body { font-family: 'Inter', sans-serif; background: #f9fafb; color: #212529; margin: 0; }
    header { background: #0a0a0a; padding: 1rem 2rem; display: flex; justify-content: space-between; align-items: center; position: sticky; top: 0; z-index: 1000; }
    header img { height: 44px; }
    nav a { margin-left: 1.5rem; color: #fff; text-decoration: none; font-weight: 500; }
    nav a:hover { color: #0d6efd; }
    .hero {
      background: linear-gradient(rgba(0,0,0,0.6), rgba(0,0,0,0.6)),
        url('https://images.unsplash.com/photo-1588776814546-ec7bc3d6c1fa?ixlib=rb-4.0.3&auto=format&fit=crop&w=2100&q=80')
        center/cover no-repeat;
      color: #fff;
      text-align: center;
      padding: 6rem 1rem;
    }
    .hero h1 {
      font-family: 'Merriweather', serif;
      font-size: 2.8rem;
    }
    .hero p {
      max-width: 1000px;
      margin: 1rem auto 0;
      color: #dee2e6;
      font-size: 1.15rem;
    }
    .controls { display: flex; flex-wrap: wrap; gap: 1rem; margin: 2rem 2rem; }
    .table-wrapper { width: 100%; overflow-x: auto; padding: 0 2rem 4rem 2rem; }
    table { width: 100%; border-collapse: collapse; table-layout: auto; min-width: 1200px; }
    th, td { padding: 0.75rem 1rem; border: 1px solid #dee2e6; text-align: left; vertical-align: top; }
    th { background: #f8f9fa; font-weight: 600; white-space: nowrap; }
    tbody tr:nth-child(even) { background: #fdfdfe; }
    tbody tr:hover { background: #e9ecef; }
    .sparkline { height: 40px; width: 100px; }
    footer { background: #0a0a0a; color: #adb5bd; text-align: center; padding: 2rem 1rem; }
    footer a { color: #0d6efd; }
  </style>
</head>

<body>

<header>
  <a href="index.html"><img src="statmint_logo.jpeg" alt="Statmint Logo"></a>
  <nav>
    <a href="index.html">Home</a>
    <a href="stocks.html">Healthcare Stocks</a>
    <a href="fda.html">FDA Pipeline</a>
    <a href="ipos.html">Biotech IPOs</a>
  </nav>
</header>

<section class="hero" data-aos="fade-down">
  <h1 data-aos="fade-up" data-aos-delay="100">Healthcare Stocks</h1>
  <p data-aos="fade-up" data-aos-delay="200">
    Monitor clinical-stage healthcare companies with real pipeline insights, stock trends, and trial status in a single dashboard.
  </p>
</section>

<section class="controls" data-aos="fade-up" data-aos-delay="300">
  <input type="text" id="searchBox" class="form-control" placeholder="Search company, candidate, or indication">
  <select id="phaseFilter" class="form-select" style="max-width:200px;">
    <option value="">All Phases</option>
    <option value="Phase I">Phase I</option>
    <option value="Phase II">Phase II</option>
    <option value="Phase III">Phase III</option>
    <option value="Regulatory Review">Regulatory Review</option>
  </select>
  <button id="downloadCSV" class="btn btn-primary">Download CSV</button>
</section>

<section class="table-wrapper">
  <table>
    <thead>
      <tr>
        <th>Company</th>
        <th>Summary</th>
        <th>Ticker</th>
        <th>Candidate</th>
        <th>Indication</th>
        <th>Phase</th>
        <th>Trial Status</th>
        <th>Competitors</th>
        <th>IPO Date</th>
        <th>Price Trend</th>
        <th>Links</th>
      </tr>
    </thead>
    <tbody id="pipeline-table-body"></tbody>
  </table>
</section>

<footer>
  <p>© 2025 Statmint. For research use only. <a href="#">Privacy Policy</a>.</p>
</footer>

<script src="https://unpkg.com/aos@2.3.4/dist/aos.js"></script>
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
<script>
  AOS.init({ duration: 800, once: true, easing: 'ease-in-out' });

  const pipeline = [
    add this to the code: [
  {
    "name": "Moderna",
    "summary": "Leader in mRNA technology developing vaccines and therapeutics across infectious diseases, oncology, and rare diseases.",
    "ticker": "MRNA",
    "candidate": "mRNA-1345",
    "indication": "RSV Vaccine (Older Adults)",
    "phase": "Phase III",
    "trialStatus": "Primary endpoint met; BLA filing expected late 2024.",
    "competitors": ["Pfizer", "GSK"],
    "ipoDate": "Dec 2018",
    "prices": [140, 145, 142, 148, 150, 153, 155, 160, 162, 158, 155, 150],
    "website": "https://www.modernatx.com"
  },
  {
    "name": "BioNTech",
    "summary": "German biotech innovator in mRNA-based immunotherapies for oncology and infectious diseases.",
    "ticker": "BNTX",
    "candidate": "BNT162b2 Combo",
    "indication": "COVID-19 + Influenza Combo Vaccine",
    "phase": "Phase II/III",
    "trialStatus": "Enrolling; interim data mid-2024.",
    "competitors": ["Moderna", "CureVac"],
    "ipoDate": "Oct 2019",
    "prices": [100, 98, 95, 97, 99, 102, 105, 104, 107, 110, 108, 105],
    "website": "https://biontech.com"
  },
  {
    "name": "Vertex Pharmaceuticals",
    "summary": "Biotech leader in cystic fibrosis treatment, expanding into pain and gene editing therapeutics.",
    "ticker": "VRTX",
    "candidate": "VX-548",
    "indication": "Non-opioid Pain Treatment",
    "phase": "Phase III",
    "trialStatus": "Pivotal trials enrolling; NDA expected 2025.",
    "competitors": ["Pfizer", "Eli Lilly"],
    "ipoDate": "Jul 1991",
    "prices": [300, 310, 320, 315, 318, 325, 330, 340, 335, 345, 340, 335],
    "website": "https://www.vrtx.com"
  },
  {
    "name": "Alnylam Pharmaceuticals",
    "summary": "Leader in RNA interference therapies for rare genetic diseases and other serious conditions.",
    "ticker": "ALNY",
    "candidate": "Vutrisiran",
    "indication": "ATTR Amyloidosis",
    "phase": "Phase III",
    "trialStatus": "Phase III readout expected Q3 2024.",
    "competitors": ["Ionis Pharmaceuticals"],
    "ipoDate": "Jun 2004",
    "prices": [190, 195, 192, 198, 200, 205, 202, 207, 210, 208, 205, 200],
    "website": "https://www.alnylam.com"
  },
  {
    "name": "CRISPR Therapeutics",
    "summary": "Developer of CRISPR/Cas9 gene-editing therapies targeting hemoglobinopathies and oncology.",
    "ticker": "CRSP",
    "candidate": "CTX001",
    "indication": "Beta Thalassemia & Sickle Cell",
    "phase": "Regulatory Review",
    "trialStatus": "BLA submitted; FDA review ongoing 2024.",
    "competitors": ["Bluebird Bio"],
    "ipoDate": "Oct 2016",
    "prices": [50, 52, 55, 57, 59, 60, 63, 65, 62, 60, 58, 57],
    "website": "https://www.crisprtx.com"
  },
  {
    "name": "Regeneron Pharmaceuticals",
    "summary": "Biotech giant developing monoclonal antibodies for serious diseases, with an expanding immuno-oncology pipeline.",
    "ticker": "REGN",
    "candidate": "Odronextamab",
    "indication": "Relapsed/Refractory Lymphoma",
    "phase": "Phase II/III",
    "trialStatus": "Pivotal study enrolling, data expected late 2024.",
    "competitors": ["Roche", "AbbVie"],
    "ipoDate": "Apr 1991",
    "prices": [800, 820, 810, 830, 835, 840, 850, 845, 855, 860, 855, 850],
    "website": "https://www.regeneron.com"
  },
  {
    "name": "Beam Therapeutics",
    "summary": "Biotech innovator in precision base-editing gene therapy platforms targeting genetic diseases.",
    "ticker": "BEAM",
    "candidate": "BEAM-101",
    "indication": "Sickle Cell Disease",
    "phase": "Phase I/II",
    "trialStatus": "First patients dosed; early readout expected Q1 2025.",
    "competitors": ["CRISPR Therapeutics", "Bluebird Bio"],
    "ipoDate": "Feb 2020",
    "prices": [40, 42, 43, 44, 46, 47, 48, 49, 50, 52, 51, 50],
    "website": "https://www.beamtx.com"
  },
  {
    "name": "Intellia Therapeutics",
    "summary": "Develops in vivo and ex vivo CRISPR gene-editing treatments for rare diseases and cancer.",
    "ticker": "NTLA",
    "candidate": "NTLA-2002",
    "indication": "Hereditary Angioedema",
    "phase": "Phase I/II",
    "trialStatus": "Dose escalation ongoing; interim data late 2024.",
    "competitors": ["Ionis", "Takeda"],
    "ipoDate": "May 2016",
    "prices": [35, 37, 38, 36, 39, 40, 42, 41, 43, 45, 44, 42],
    "website": "https://www.intelliatx.com"
  },
  {
    "name": "Sarepta Therapeutics",
    "summary": "Focused on precision genetic medicine to treat neuromuscular diseases like Duchenne muscular dystrophy.",
    "ticker": "SRPT",
    "candidate": "SRP-9001",
    "indication": "Duchenne Muscular Dystrophy",
    "phase": "Regulatory Review",
    "trialStatus": "BLA submitted; FDA decision expected 2024.",
    "competitors": ["Pfizer", "Solid Biosciences"],
    "ipoDate": "Jun 1997",
    "prices": [120, 123, 125, 127, 130, 128, 126, 129, 131, 130, 128, 126],
    "website": "https://www.sarepta.com"
  },
  {
    "name": "Immunocore Holdings",
    "summary": "Pioneer in T cell receptor (TCR) therapeutics for cancer and infectious diseases.",
    "ticker": "IMCR",
    "candidate": "IMC-F106C",
    "indication": "Cutaneous Melanoma",
    "phase": "Phase I/II",
    "trialStatus": "Phase II expansion ongoing; data update Q4 2024.",
    "competitors": ["Bristol Myers Squibb", "Merck"],
    "ipoDate": "Feb 2021",
    "prices": [55, 58, 57, 60, 62, 63, 64, 66, 65, 67, 66, 65],
    "website": "https://www.immunocore.com"
  },
  {
    "name": "Relay Therapeutics",
    "summary": "Uses dynamic protein motion insights to design precision small molecule therapies for oncology and genetic diseases.",
    "ticker": "RLAY",
    "candidate": "RLY-4008",
    "indication": "Cholangiocarcinoma",
    "phase": "Phase II",
    "trialStatus": "Phase II expansion study underway.",
    "competitors": ["Blueprint Medicines"],
    "ipoDate": "Jul 2020",
    "prices": [12, 14, 13, 15, 16, 17, 18, 17, 16, 15, 16, 17],
    "website": "https://www.relaytx.com"
  },
  {
    "name": "Verve Therapeutics",
    "summary": "Develops single-course gene-editing treatments to permanently lower LDL cholesterol.",
    "ticker": "VERV",
    "candidate": "VERVE-101",
    "indication": "Familial Hypercholesterolemia",
    "phase": "Phase I",
    "trialStatus": "Dose escalation ongoing; initial data mid-2024.",
    "competitors": ["Alnylam", "Ionis"],
    "ipoDate": "Jun 2021",
    "prices": [20, 22, 21, 23, 24, 25, 26, 27, 26, 25, 24, 23],
    "website": "https://www.vervetx.com"
  },
  {
    "name": "Editas Medicine",
    "summary": "Develops CRISPR-based in vivo gene editing medicines for genetic diseases including inherited blindness.",
    "ticker": "EDIT",
    "candidate": "EDIT-101",
    "indication": "Leber Congenital Amaurosis",
    "phase": "Phase I/II",
    "trialStatus": "Dose escalation ongoing; Phase II data mid-2024.",
    "competitors": ["CRISPR Therapeutics"],
    "ipoDate": "Feb 2016",
    "prices": [8, 9, 8.5, 9.5, 10, 10.5, 11, 11.5, 11, 10.5, 10, 9.5],
    "website": "https://www.editasmedicine.com"
  },
  {
    "name": "Sana Biotechnology",
    "summary": "Develops engineered cells for in vivo regeneration and ex vivo cell therapies for oncology and genetic diseases.",
    "ticker": "SANA",
    "candidate": "SG295",
    "indication": "Liver Regeneration",
    "phase": "Phase I",
    "trialStatus": "First patients treated; safety data expected 2024.",
    "competitors": ["Beam Therapeutics"],
    "ipoDate": "Feb 2021",
    "prices": [5, 5.5, 5.8, 6, 6.5, 6.8, 7, 7.2, 7, 6.8, 6.5, 6.2],
    "website": "https://www.sanabiotech.com"
  },
  {
    "name": "Arcus Biosciences",
    "summary": "Focused on innovative cancer immunotherapies including small molecules and antibodies for multiple tumor types.",
    "ticker": "RCUS",
    "candidate": "Domvanalimab",
    "indication": "Non-small Cell Lung Cancer",
    "phase": "Phase III",
    "trialStatus": "Pivotal trial enrolling; interim data 2025.",
    "competitors": ["Merck", "Bristol Myers Squibb"],
    "ipoDate": "Mar 2018",
    "prices": [20, 21, 21.5, 22, 22.5, 23, 23.5, 24, 23.8, 23.5, 23, 22.5],
    "website": "https://www.arcusbio.com"
  }
]/* ✅ PASTE THE FULL JSON YOU POSTED HERE EXACTLY */];

  const labels = ["Jul 2023","Aug","Sep","Oct","Nov","Dec","Jan","Feb","Mar","Apr","May","Jun"];
  const tbody = document.getElementById('pipeline-table-body');
  const searchBox = document.getElementById('searchBox');
  const phaseFilter = document.getElementById('phaseFilter');
  const downloadCSV = document.getElementById('downloadCSV');

  function renderTable() {
    tbody.innerHTML = "";
    const search = searchBox.value.toLowerCase();
    const phase = phaseFilter.value;
    let rowIdx = 0;
    pipeline.forEach((entry) => {
      const matchSearch = [entry.name, entry.candidate, entry.indication].some(field =>
        field.toLowerCase().includes(search)
      );
      const matchPhase = !phase || entry.phase === phase;
      if (matchSearch && matchPhase) {
        const row = document.createElement('tr');
        row.setAttribute('data-aos', 'fade-up');
        row.setAttribute('data-aos-delay', `${100 + rowIdx * 50}`);
        row.innerHTML = `
          <td>${entry.name}</td>
          <td>${entry.summary}</td>
          <td>${entry.ticker}</td>
          <td>${entry.candidate}</td>
          <td>${entry.indication}</td>
          <td>${entry.phase}</td>
          <td>${entry.trialStatus}</td>
          <td>${entry.competitors.join(', ')}</td>
          <td>${entry.ipoDate}</td>
          <td><canvas id="spark-${rowIdx}" class="sparkline"></canvas></td>
          <td>
            <a href="${entry.website}" target="_blank">IR Page</a> |
            <a href="https://finance.yahoo.com/quote/${entry.ticker}" target="_blank">Yahoo Finance</a>
          </td>
        `;
        tbody.appendChild(row);
        const ctx = document.getElementById(`spark-${rowIdx}`).getContext('2d');
        new Chart(ctx, {
          type: 'line',
          data: {
            labels: labels,
            datasets: [{
              data: entry.prices,
              borderColor: '#0d6efd',
              backgroundColor: 'transparent',
              tension: 0.3
            }]
          },
          options: {
            plugins: { legend: { display: false } },
            scales: { x: { display: false }, y: { display: false } },
            elements: { point: { radius: 0 } }
          }
        });
        rowIdx++;
      }
    });
  }

  searchBox.addEventListener('input', renderTable);
  phaseFilter.addEventListener('change', renderTable);
  downloadCSV.addEventListener('click', () => {
    let csv = 'Company,Summary,Ticker,Candidate,Indication,Phase,Trial Status,Competitors,IPO Date\n';
    const search = searchBox.value.toLowerCase();
    const phase = phaseFilter.value;
    pipeline.forEach(entry => {
      const matchSearch = [entry.name, entry.candidate, entry.indication].some(field =>
        field.toLowerCase().includes(search)
      );
      const matchPhase = !phase || entry.phase === phase;
      if (matchSearch && matchPhase) {
        csv += `"${entry.name}","${entry.summary}","${entry.ticker}","${entry.candidate}","${entry.indication}","${entry.phase}","${entry.trialStatus}","${entry.competitors.join('; ')}","${entry.ipoDate}"\n`;
      }
    });
    const blob = new Blob([csv], { type: 'text/csv' });
    const link = document.createElement('a');
    link.href = URL.createObjectURL(blob);
    link.download = 'Statmint_Healthcare_Stocks.csv';
    link.click();
  });

  renderTable();
</script>

</body>
</html>
